---
title: "EVOX THERAPEUTICS LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/aceacf32-148f-590b-8a3d-e858688f7078
json: https://whiteintel.dev/api/public/dossier/aceacf32-148f-590b-8a3d-e858688f7078
identifier: oo:GB-COH-10076821
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# EVOX THERAPEUTICS LIMITED

**Type:** Company  
**Jurisdiction:** GB  
**Identifier:** `oo:GB-COH-10076821`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/aceacf32-148f-590b-8a3d-e858688f7078  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/aceacf32-148f-590b-8a3d-e858688f7078  

## Ownership & control

### Owners / controllers

- **OXFORD SCIENCE ENTERPRISES PLC** (beneficial owner) — 50% — https://whiteintel.dev/entity/23368d2b-9696-5261-8a95-3dcac8b35a88
- **OXFORD SCIENCE ENTERPRISES PLC** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/23368d2b-9696-5261-8a95-3dcac8b35a88

### UBO chain (walk to the ultimate owner)

A **2-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `10076821`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2016-03-22
- **Registered office:** Medawar Centre 2nd Floor East Building, Robert Robinson Avenue, Oxford, Oxfordshire, OX4 4HG, United Kingdom
- **SIC:** 72110

### Officers

- ANDREWS, Martin — director · British · appointed 2020-05-16
- CAPLAN, Evan Samuel, Dr — director · American · appointed 2022-04-13
- FEINLEIB, Laura Ann Taylor — director · American · appointed 2025-03-13
- GORDON WILD, Sarah Lucinda — director · British · appointed 2017-03-15
- LUNDIN, Per, Dr — director · Swedish · appointed 2024-04-26
- TRECO, Douglas — director · American · appointed 2025-10-20
- WALLACE, Wallace Lucy Elizabeth — director · British · appointed 2025-09-12
- CARTER, Paul Rutherford — director · British · appointed 2020-04-17 · resigned 2024-04-26
- HAMMACHER, Alexander Eric — director · British · appointed 2023-09-21 · resigned 2025-09-09
- KHUONG, Chau Q. — director · American · appointed 2021-02-16 · resigned 2022-03-01
- LUNDIN, Per, Dr — director · Swedish · appointed 2016-04-07 · resigned 2021-02-16
- MCHUTCHISON, John George — director · American · appointed 2021-01-06 · resigned 2023-09-21
- MCLEAN, Andrew James, Dr — director · British · appointed 2016-03-22 · resigned 2020-06-30
- MOSES, Edwin, Dr — director · British · appointed 2019-02-08 · resigned 2020-03-23
- NAGPAL, Amrit — director · American · appointed 2019-02-08 · resigned 2025-03-13
- ROLLET DE FOUGEROLLES, Antonin Robert, Dr — director · Canadian · appointed 2017-10-17 · resigned 2024-04-26
- STOTEN, Adam, Dr — director · British · appointed 2016-04-07 · resigned 2019-02-05
- WOOD, Matthew John Andrew, Prof — director · Irish · appointed 2016-04-07 · resigned 2021-02-16

### Beneficial owners (Persons with Significant Control)

- [Oxford Science Enterprises Plc](https://whiteintel.dev/entity/23368d2b-9696-5261-8a95-3dcac8b35a88) — 25–50% shares · corporate PSC · United Kingdom — since 2016-04-06

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/10076821
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/10076821

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **EVOX THERAPEUTICS LIMITED**. Human view: https://whiteintel.dev/entity/aceacf32-148f-590b-8a3d-e858688f7078 · Structured JSON: https://whiteintel.dev/api/public/dossier/aceacf32-148f-590b-8a3d-e858688f7078._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._